Jury Awards $2.5 Million In Birth Defects Linked To Paxil
View Mobile Site
Save Email Print
Jury Awards $2.5 Million In Birth Defects Linked To Paxil
A jury has ordered a drug maker to pay $2.5 million in a suit over birth defects allegedly caused by the antidepressant drug Paxil.
Font Size:

PHILADELPHIA (October 14, 2009)—A jury in Philadelphia has ordered drug maker GlaxoSmithKline to pay $2.5 million in a lawsuit over birth defects allegedly caused by the company’s antidepressant drug Paxil.

The verdict is the first in about 600 similar Paxil lawsuits filed around the country.

The jury found the company was negligent, but that its conduct was not outrageous, and rejected punitive damages.

Plaintiff Michelle David of suburban Philadelphia has a son born four years ago with several heart defects.

The child spent months in the hospital and has had several surgeries.

The family's lawyer says he will need at least one more operation.

GlaxoSmithKline says it plans to appeal the verdict.

The U.S. Food and Drug Administration issued warnings in 2005 that Paxil may be associated with birth defects.

Spotlight on Health
KWTX.com Features
Double Dollar Deals
Half Price Deals at Central Texas restaurants and businesses. A new deal every Thursday at 7:00am.
Boss of the Month
Who is Central Texas’ best boss? Nominate your supervisor for Boss of the Month!
Golden Apple
Your chance to nominate an outstanding teacher. Find out how they are making a difference in classrooms.
Emily Wants to Know
Emily Matthews' inquisitive look at life in Central Texas.
Army Way
Learn all about the symbols, traditions, and customs of the US Army.
For Your Health